Finland's pharma industry investments rose to 227 million euros last year

10 April 2017

In 2016, the total value of pharmaceutical industry investments rose to 227 million euros ($242 million) from 220 million euros in the previous year. The growth was particularly marked in R&D investments.

In addition to investments, the branch sees signs of a positive growth trend both in the number of clinical trials and of patients participating in them. According to the investment survey performed by trade group Pharma Industry Finland (PIF), the pharmaceutical companies are particularly interested in increasing their register-based research operations in Finland. For example, the research on adverse effects of medicines utilizes register data.

The favorable trend in the investments made by pharmaceutical companies enhances the branch’s role as a promising actor promoting economic growth in Finland.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK